相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective Study
Marie des Neiges Santin et al.
MOVEMENT DISORDERS (2021)
Structural and functional correlates of subthalamic deep brain stimulation-induced apathy in Parkinson's disease
Lennard I. Boon et al.
BRAIN STIMULATION (2021)
Apathy Induced by Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A Meta-Analysis
Thomas J. C. Zoon et al.
MOVEMENT DISORDERS (2021)
Reader Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes
Christos Sidiropoulos
NEUROLOGY (2021)
What predicts quality of life after subthalamic deep brain stimulation in Parkinson's disease? A systematic review
V. J. Geraedts et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Initiation of pharmacological therapy in Parkinson's disease: when, why, and how
Rob M. A. de Bie et al.
LANCET NEUROLOGY (2020)
Management of Impulse Control Disorders with Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Deborah Amstutz et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2020)
Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study
Jerrold L. Vitek et al.
LANCET NEUROLOGY (2020)
Deep brain stimulation in early-stage Parkinson disease Five-year outcomes
Mallory L. Hacker et al.
NEUROLOGY (2020)
Impulse control disorders in Parkinson's disease: A 20-year odyssey
Daniel Weintraub
MOVEMENT DISORDERS (2019)
Long-term outcomes of deep brain stimulation in Parkinson disease
Patricia Limousin et al.
NATURE REVIEWS NEUROLOGY (2019)
Quality of life predicts outcome of deep brain stimulation in early Parkinson disease
W. M. Michael Schuepbach et al.
NEUROLOGY (2019)
Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease
C. V. M. Verschuur et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Biomarkers for closed-loop deep brain stimulation in Parkinson disease and beyond
Walid Bouthour et al.
NATURE REVIEWS NEUROLOGY (2019)
Deep Brain Stimulation in Movement Disorders: From Experimental Surgery to Evidence-Based Therapy
Paul Krack et al.
MOVEMENT DISORDERS (2019)
The Neuropsychiatry of Parkinson Disease: A Perfect Storm
Daniel Weintraub et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2019)
Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease
Maria Jose Catalan et al.
JOURNAL OF NEUROLOGY (2018)
Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort study
Marie Abbes et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial
Eugenie Lhommee et al.
LANCET NEUROLOGY (2018)
Longitudinal analysis of impulse control disorders in Parkinson disease
Jean-Christophe Corvol et al.
NEUROLOGY (2018)
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
Regina Katzenschlager et al.
LANCET NEUROLOGY (2018)
Hyperdopaminergic behavioral spectrum in Parkinson's disease: A review
Matthieu Bereau et al.
REVUE NEUROLOGIQUE (2018)
Neuropsychological Outcomes From Constant Current Deep Brain Stimulation for Parkinson's Disease
Alexander I. Troster et al.
MOVEMENT DISORDERS (2017)
A Retrospective Evaluation of the Frequency of Impulsive Compulsive Behaviors in Parkinson's Disease Patients Treated with Continuous Waking Day Apomorphine Pumps
Pedro Barbosa et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2017)
Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease
Kara M. Smith et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease
Raul Martinez-Fernandez et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease
Audrey Maillet et al.
BRAIN (2016)
The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations
Raul Martinez-Fernandez et al.
MOVEMENT DISORDERS (2016)
Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment
Javier Pagonabarraga et al.
LANCET NEUROLOGY (2015)
Management of Impulse Control Disorders in Parkinson's Disease: Controversies and Future Approaches
Michael Samuel et al.
MOVEMENT DISORDERS (2015)
Central Pharmacokinetics of Levodopa: Lessons From Imaging Studies
A. Jon Stoessl
MOVEMENT DISORDERS (2015)
'Don't delay, start today': delaying levodopa does not delay motor complications
Susan H. Fox et al.
BRAIN (2014)
The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
Roberto Cilia et al.
BRAIN (2014)
for the LCIG Horizon Study Group. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study (vol 13, pg 141, 2014)
C. W. Olen et al.
LANCET NEUROLOGY (2014)
Mood and behavioural effects of subthalamic stimulation in Parkinson's disease
Anna Castrioto et al.
LANCET NEUROLOGY (2014)
Stimulation of the subthalamic area modulating movement and behavior
L. Ricciardi et al.
PARKINSONISM & RELATED DISORDERS (2014)
Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease
David Charles et al.
PARKINSONISM & RELATED DISORDERS (2014)
Acute and Chronic Mood and Apathy Outcomes from a Randomized Study of Unilateral STN and GPi DBS
Michael S. Okun et al.
PLOS ONE (2014)
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
C. Warren Olanow et al.
LANCET NEUROLOGY (2014)
Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil
Stephane Thobois et al.
BRAIN (2013)
Psychostimulant effect of levodopa: reversing sensitisation is possible
Anna Castrioto et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease
Alexandre Eusebio et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial
Vincent J J Odekerken et al.
LANCET NEUROLOGY (2013)
Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease
C. Warren Olanow et al.
MOVEMENT DISORDERS (2013)
Neurostimulation for Parkinson's Disease with Early Motor Complications
W. M. M. Schuepbach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours
Eugenie Lhommee et al.
BRAIN (2012)
Addiction-Like Manifestations and Parkinson's Disease: A Large Single Center 9-Year Experience
Natlada Limotai et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2012)
Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial (vol 11, pg 140, 2012)
M. S. Okun et al.
LANCET NEUROLOGY (2012)
Effects of STN and GPi Deep Brain Stimulation on Impulse Control Disorders and Dopamine Dysregulation Syndrome
Sarah J. Moum et al.
PLOS ONE (2012)
Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial
Michael S. Okun et al.
LANCET NEUROLOGY (2012)
Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's Disease
Harriet M. M. Smeding et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
The natural history of treated Parkinson's disease in an incident, community based cohort
Jonathan R. Evans et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease
Karsten Witt et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
The Impact of Non-Motor Symptoms on Health-Related Quality of Life of Patients with Parkinson's Disease
Pablo Martinez-Martin et al.
MOVEMENT DISORDERS (2011)
Maladaptive Plasticity of Serotonin Axon Terminals in Levodopa-Induced Dyskinesia
Daniella Rylander et al.
ANNALS OF NEUROLOGY (2010)
Impulse Control Disorders in Parkinson Disease A Cross-Sectional Study of 3090 Patients
Daniel Weintraub et al.
ARCHIVES OF NEUROLOGY (2010)
Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation
Stephane Thobois et al.
BRAIN (2010)
Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial
Adrian Williams et al.
LANCET NEUROLOGY (2010)
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap
Paolo Calabresi et al.
LANCET NEUROLOGY (2010)
Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease
Kenneth A. Follett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Stimulation of the Subthalamic Nucleus and Impulsivity: Release Your Horses
Benedicte Ballanger et al.
ANNALS OF NEUROLOGY (2009)
Cognition and Mood in Parkinson's Disease in Subthalamic Nucleus versus Globus Pallidus Interna Deep Brain Stimulation: The COMPARE Trial
Michael S. Okun et al.
ANNALS OF NEUROLOGY (2009)
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study
T. D. L. Steeves et al.
BRAIN (2009)
Dopamine Dysregulation Syndrome An Overview of its Epidemiology, Mechanisms and Management
Sean S. O'Sullivan et al.
CNS DRUGS (2009)
Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease A Randomized Controlled Trial
Frances M. Weaver et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease:: a randomised, multicentre study
Karsten Witt et al.
LANCET NEUROLOGY (2008)
Molecular mechanisms of L-DOPA-induced dyskinesia
Peter Jenner
NATURE REVIEWS NEUROSCIENCE (2008)
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD
R. Katzenschlager et al.
NEUROLOGY (2008)
Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease
Tatiana Witjas et al.
MOVEMENT DISORDERS (2007)
Does ageing influence deep brain stimulation outcomes in Parkinson's disease?
Fabienne Ory-Magne et al.
MOVEMENT DISORDERS (2007)
Levodopa-induced hyperactivity in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Anthony P. Nicholas
MOVEMENT DISORDERS (2007)
Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease
Robert A. Hauser et al.
ARCHIVES OF NEUROLOGY (2006)
Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation
Claire Ardouin et al.
MOVEMENT DISORDERS (2006)
A randomized trial of deep-brain stimulation for Parkinson's disease
Guenther Deuschl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Compulsive drug use linked to sensitized ventral striatal dopamine transmission
AH Evans et al.
ANNALS OF NEUROLOGY (2006)
Deep brain stimulation: Postoperative issues
Guenther Deuschl et al.
MOVEMENT DISORDERS (2006)
Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation
T Witjas et al.
MOVEMENT DISORDERS (2005)
Management of referred deep brain stimulation failures - A retrospective analysis from 2 movement disorders centers
MS Okun et al.
ARCHIVES OF NEUROLOGY (2005)
Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?
V Czernecki et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease:: implications for dyskinesias
R de la Fuente-Fernández et al.
BRAIN (2004)
Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease
A Funkiewiez et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?
AD Lawrence et al.
LANCET NEUROLOGY (2003)
Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease
A Funkiewiez et al.
MOVEMENT DISORDERS (2003)
Predictors of effective bilateral subthalamic nucleus stimulation for PD
PD Charles et al.
NEUROLOGY (2002)
Nonmotor fluctuations in Parkinson's disease -: Frequent and disabling
T Witjas et al.
NEUROLOGY (2002)
Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons
MA Ungless et al.
NATURE (2001)
Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
JE Ahlskog et al.
MOVEMENT DISORDERS (2001)
Dyskinesias and motor fluctuations in Parkinson's disease - A community-based study
A Schrag et al.
BRAIN (2000)
Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies
G Giovannoni et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
分享论文
